ENVERIC BIOSCIENCES, INC. Operating Leases, Future Minimum Payments, Due in Four Years
ENVERIC BIOSCIENCES, INC. (ENVB) had Operating Leases, Future Minimum Payments, Due in Four Years of $7.37 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2018-11-14
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $7.37K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $7.37K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $7.37K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $7.37K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-09-30 | $7.37K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $7.37K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.37K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $7.37K 10-K · filed 2018-04-02 |
| 2017-09-30 | $70.33K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $70.33K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |